Cryotherapy, also known as cryosurgery or cryoablation, is a minimally invasive treatment used to destroy prostate cancer cells by freezing them. At KIMS, our Renal Sciences team uses advanced cryotherapy techniques as an effective alternative to traditional surgery or radiation, especially for early-stage prostate cancer or recurrent cases after other treatments.
During the procedure, thin, needle-like probes are inserted into the prostate gland under the guidance of advanced imaging techniques such as ultrasound. These probes deliver extremely cold gases (typically argon or nitrogen) that freeze and destroy cancerous tissue. The treatment is performed under anesthesia and typically takes just a few hours, with minimal recovery time.
Cryotherapy works by forming ice crystals inside the cancer cells, which damages the cell membranes and causes cell death. A warming catheter is usually inserted into the urethra during the procedure to protect it from freezing and maintain normal function.
Cryotherapy is often recommended for patients who are not suitable candidates for surgery or radiation, or those who prefer a less invasive approach. While it is effective in many cases, it may lead to some side effects like urinary or sexual dysfunction, which vary depending on individual factors.